STOCK TITAN

DOCS insider sale of 2,000 shares at $70.01 and option exercise

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Doximity insiders reported coordinated transactions on 10/01/2025. Reporting person Kira Wampler, a director, sold 2,000 shares of Class A common stock at $70.01 and concurrently acquired 2,000 shares through conversion/exercise activity tied to outstanding Class B shares and stock options. After these transactions the reporting person beneficially owned 19,839 shares of Class A common stock and 466,700 shares of Class B common stock (equivalent to Class A on conversion). The sale executed under a pre-existing Rule 10b5-1 plan adopted on 11/12/2024, and the stock option exercised carries a $1.54 exercise price with a 06/09/2030 expiration for the vested portion.

Positive

  • Sale executed under a Rule 10b5-1 plan, indicating pre-planned, non-discretionary disposition
  • Options vested and exercised at a low strike of $1.54, demonstrating value capture from long-dated grants

Negative

  • Insider sold 2,000 shares at $70.01, reducing direct Class A holdings from reported levels
  • Beneficial ownership of Class A shares decreased to 19,839 following the sale

Insights

Insider used a Rule 10b5-1 plan for an automatic sale and exercised vested options.

The Form 4 shows a Rule 10b5-1 plan triggered the sale of 2,000 Class A shares at $70.01, indicating pre-planned disposition rather than an ad-hoc sale.

The reporting person also exercised or converted instruments that netted 2,000 shares, reflecting routine option vesting and conversion mechanics tied to Class B shares.

Vesting schedule and option economics are explicit: $1.54 strike, vested monthly since 2020.

The exercised stock option has a $1.54 exercise price and vested in monthly installments after 3/27/2020; the option grant date was 6/10/2020. The exercised shares add 2,000 Class A-equivalent shares to beneficial ownership.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Wampler Kira Scherer

(Last) (First) (Middle)
C/O DOXIMITY, INC.
500 THIRD STREET

(Street)
SAN FRANCISCO CA 94107

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Doximity, Inc. [ DOCS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 10/01/2025 C(1) 2,000 A (1) 21,839 D
Class A Common Stock 10/01/2025 S(2) 2,000 D $70.01 19,839 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) $1.54 10/01/2025 M 2,000 (3) 06/09/2030 Class B Common Stock(4) 2,000 $0 466,700 D
Class B Common Stock (4) 10/01/2025 M 2,000 (4) (4) Class A Common Stock 2,000 $0 2,000 D
Class B Common Stock (4) 10/01/2025 C 2,000 (4) (4) Class A Common Stock 2,000 $0 0 D
Explanation of Responses:
1. Each share of Class B Common Stock, par value $0.001 per share (the "Class B Common Stock"), converted into one share of Class A Common Stock, par value $0.001 per share (the "Class A Common Stock"), at the option of the holder.
2. The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 12, 2024.
3. The stock option vested in 36 equal monthly installments after March 27, 2020, subject to the Reporting Person's continuous service relationship with the Issuer through each applicable vesting date. The stock option was granted on June 10, 2020.
4. Each share of Class B Common Stock is convertible into one share of Class A Common Stock at any time at the option of the holder. Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock, upon the following: (1) the sale or transfer of such share of Class B Common Stock, except for certain permitted transfers described in the Issuer's amended and restated certificate of incorporation; (2) the death or incapacity of the Reporting Person; and (3) on the final conversion date, defined as the earlier of (a) the tenth anniversary of the effectiveness of the registration statement in connection with the Issuer's initial public offering; or (b) the date specified by a vote of the holders of at least 66 2/3% of the outstanding shares of Class B Common Stock, voting as a single class.
Remarks:
Exhibit 24 - Power of Attorney
/s/ John Vaughan, Attorney-in-Fact 10/03/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the Doximity (DOCS) Form 4 filed by Kira Wampler report?

The Form 4 reports a sale of 2,000 Class A shares at $70.01, conversion/exercise activity resulting in 2,000 acquired shares, and post-transaction beneficial ownership of 19,839 Class A and 466,700 Class B shares.

Was the sale under a trading plan for DOCS insider activity?

Yes. The sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted on 11/12/2024.

What option details are disclosed in the DOCS Form 4?

A stock option with a $1.54 exercise price (grant date 6/10/2020) vested in monthly installments after 3/27/2020; exercised or otherwise converted to 2,000 shares.

How many Class B shares does the reporting person hold after the transactions?

The Form 4 shows beneficial ownership of 466,700 Class B common shares following the reported transactions.

Did conversion rules affect the reported share counts in the DOCS filing?

Yes. The filing explains that Class B shares are convertible one-for-one into Class A shares and may convert on transfer, death/incapacity, or a specified final conversion date.
Doximity Inc

NYSE:DOCS

DOCS Rankings

DOCS Latest News

DOCS Latest SEC Filings

DOCS Stock Data

7.61B
134.21M
2.29%
90.53%
2.51%
Health Information Services
Services-computer Programming Services
Link
United States
SAN FRANCISCO